Cargando…
Novel sublingual tablets of Atorvastatin calcium/Trimetazidine hydrochloride combination; HPTLC quantification, in vitro formulation and characterization
BACKGROUND: Ischemic heart disorders and accumulation of lipids in blood vessels could contribute to angina pectoris. Therefore, the aim of this study was to formulate sublingual tablets containing a novel combination of Atorvastatin calcium (ATOR) and Trimetazidine HCl (TMZ) for efficient treatment...
Autores principales: | Atia, Noha N., Tawfeek, Hesham M., Rageh, Azza H., El-Zahry, Marwa R., Abdelfattah, Ahmed, Younis, Mahmoud A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488851/ https://www.ncbi.nlm.nih.gov/pubmed/31061623 http://dx.doi.org/10.1016/j.jsps.2019.02.001 |
Ejemplares similares
-
Formulation of sublingual promethazine hydrochloride tablets for rapid relief of motion sickness
por: Alyami, Hamad S, et al.
Publicado: (2021) -
A validated HPTLC method for estimation of moxifloxacin hydrochloride in tablets
por: Dhillon, Vandana, et al.
Publicado: (2010) -
Simultaneous RP-HPLC and HPTLC Estimation of Fluoxetine Hydrochloride and Olanzapine in Tablet Dosage Forms
por: Patel, Sejal, et al.
Publicado: (2009) -
Formulation and Evaluation of New Glimepiride Sublingual Tablets
por: Al-Madhagi, Wafa, et al.
Publicado: (2017) -
Validated HPTLC Method for Simultaneous Determination of Quinapril Hydrochloride and Hydrochlorothiazide in a Tablet Dosage Form
por: Bhavar, Girija B., et al.
Publicado: (2008)